• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010?11

Giuseppe

Emeritus
[Source: US Centers for Disease Control and Prevention, Emerging Infectious Diseases Journal, full PDF document (LINK). Abstract, edited.]


DOI: http://dx.doi.org/10.3201/eid1802.111466

Suggested citation for this article: Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan C-Y, et al. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010?11. Emerg Infect Dis [serial on the Internet]. 2012 Feb; Epub 2001 Dec 19.


Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010?11


Aaron D. Storms, Larisa V. Gubareva, Su Su, John T. Wheeling, Margaret Okomo-Adhiambo, Chao-Yang Pan, Erik Reisdorf, Kirsten St. George, Robert Myers, Jason T. Wotton, Sara Robinson, Brandon Leader, Martha Thompson, Marjorie Shannon, Alexander Klimov, and Alicia M. Fry, for the US Antiviral Resistance Surveillance Working Group (1)

Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (A.D. Storms, L.V. Gubareva, S. Su, J.T. Wheeling, M. Okomo-Adhiambo, A. Klimov, A.M. Fry); California Department of Public Health, Sacramento, California, USA (C.-Y. Pan); Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, USA (E. Reisdorf); New York State Department of Health, Albany, New York, USA (K. St. George); Maryland Department of Health and Mental Hygiene, Baltimore, Maryland, USA (R. Myers); Minnesota Department of Health, Saint Paul, Minnesota, USA (J.T. Wotton); Maine Department of Health and Human Services, Augusta, Maine, USA (S. Robinson); Washington State Department of Health, Shoreline, Washington, USA (B. Leader); Texas Department of State Health Services, Austin, Texas, USA (M. Thompson); and Delaware Health and Social Services, New Castle, Delaware, USA (M. Shannon)

(1) Additional members of the US Antiviral Resistance Surveillance Working Group who contributed data are listed at the end of this article.



During October 2010?July 2011, 1.0% of pandemic (H1N1) 2009 viruses in the United States were oseltamivir resistant, compared with 0.5% during the 2009?10 influenza season. Of resistant viruses from 2010?11 and 2009?10, 26% and 89%, respectively, were from persons exposed to oseltamivir before specimen collection. Findings suggest limited community transmission of oseltamivir-resistant virus.



-
------
 
Back
Top Bottom